A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load

Nature Protocols

Volumn 3, Issue 7, 2008, Pages 1240-1248

  Malnati, Mauro S ^a   Scarlatti, Gabriella ^a   Gatto, Francesca ^a   Salvatori, Francesca ^a   Cassina, Giulia ^a   Rutigliano, Teresa ^a   Volpi, Rosy ^a   Lusso, Paolo ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACCURACY; AMPLICON; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

COMPUTATIONAL BIOLOGY; DNA PRIMERS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PROVIRUSES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 50249111028     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2008.108     Document Type: Article

References (37)

1. Koralnik, I.J. et al. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52, 253-260 (1999).
2. Blackard, J.T. et al. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J. Infect. Dis. 192, 258-265 (2005).
3. Fontaine, J. et al. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19, 785-794 (2005).
4. Shiramizu, B. et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19, 45-52 (2005).
5. Perrin, L. et al. Multicenter performance evaluation of a newTaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J. Clin. Microbiol. 44, 4371-4375 (2006).
6. Highbarger, H.C. et al. Comparison of the Abbott 7000 and Bayer 340 systems for measurement of hepatitis C virus load. J. Clin. Microbiol. 45, 2808-2812 (2007).
7. Gueudin, M. et al. Differences in proviral DNA load between HIV-1 and HIV-2-infected patients. AIDS 22, 211-215 (2008).
8. Hatzakis, A.E. et al. Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS 18, 2261-2267 (2004).
9. Halfon, P. et al. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 44, 2507-2511 (2006).
10. Sarrazin, C. et al. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J. Clin. Microbiol. 44, 729-737 (2006).
11. Jungkind, D. et al. Automation of laboratory testing for infectious diseases using the polymerase chain reaction- our past, our present, our future. J. Clin. Virol. 20, 1-6 (2001).
12. Qu, L., Triulzi, D.J., Rowe, D.T., Griffin, D.L. & Donnenberg, A.D. Stability of lymphocytes and Epstein-Barr virus during red blood cell storage. Vox Sang 92, 125-129 (2007).
13. Henriques, I. et al. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors. Transfus. Apher. Sci. 33, 305-309 (2005).
14. Schmidt, M., Roth, W.K., Meyer, H., Seifried, E. & Hourfar, M.K. Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism. Transfusion 45, 399-403 (2005).
15. Pennington, J. et al. Persistence of HTLV-I in blood components after leukocyte depletion. Blood 100, 677-681 (2002).
16. Wongsena, W. et al. Detection of HIV-1 window period infection in blood donors using borderline anti-HIV results, HIV-1 proviral DNA PCR, and HIV-1 antigen test. J. Med. Assoc. Thai. 80 (Suppl. 1): S112-S115 (1997).
17. Neal, T.F. et al. CD34+ progenitor cells from asymptornatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86, 1749-1756 (1995).
18. + T cells. Nature 417, 95-98 (2002).
19. Chun, T.W. et al. Gene expression and viral production in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl. Acad. Sci. USA 100, 1908-1913 (2003).
20. Biswas, P. et al. Expression of CD4 on human peripheral blood neutrophils. Blood 101, 4452-4456 (2003).
21. Morsica, G. et al. Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection. Scand. J. Immunol. 62, 318-324 (2005).
22. Soulié, C. et al. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART. AIDS 21, 2243-2245 (2007).
23. Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 1295-1300 (1997).
24. Zhang, H. et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339, 1803-1809 (1998).
25. Chun, T.W. et al. Early establishment ofa pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl. Acad. Sci. USA 95, 8869-8873 (1998).
26. Pires, A. et al. Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs. J. Acquir. Immune Defic. Syndr. 36, 783-790 (2004).
27. Hasson, H. et al. Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1. J. Med. Virol. 79, 1640-1649 (2007).
28. Hughes, G.J. et al. HIV-1-infected CD8+CD4+ T cells decay in vivo at a similar rate to infected CD4 T cells during HAART. AIDS 22, 57-65 (2008).
29. Goujard, C. et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin. Infect. Dis. 42, 709-715 (2006).
30. Kostrikis, L.G. et al. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J. Viral. 76, 10099-10108 (2002).
31. Désiré, N. et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbial. 39, 1303-1310 (2001).
32. Higuchi, R. et al. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions. Biotechnol. 11, 1026-1030 (1993).
33. Salvatori, F. et al. Semi-automated real time quantitative PCR of HIV-1 strains of diverse geographical origin. Fourth European Conference on Experimental AIDS Research (ECEAR), Tampere, Finland, June 18-21, 1999. Abstract Book, p. 112.
34. Bøgh, M. et al. Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test. J. Clin. Virol. 20, 149-153 (2001).
35. Cunningham, P. et al. False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand. J. Clin. Virol. 26, 163-169 (2003).
36. Higuchi, R. et al. Simultaneous amplification and detection of specific DNA sequences. Nat. Biotechnol. 10, 413-417 (1992).
37. Lusso, P., Malnati, M. & Scarlatti, G. Method for the quantitative detection of nucleic acids EU Patent 1,131,466 (filed 17 Nov. 1999; issued 11 July 2007).